The 3rd Asian Pneumococcal Symposium

Message from the President

October 31, 2021

Welcome Message

Dear Colleagues and Friends,

On behalf of the Steering Committee Members and Scientific Program Committee, we warmly welcome you to the 3rd Asian Pneumococcal Symposium in Karuizawa, Nagano Prefecture, Japan held on December 2 and 3, 2021. This symposium will take place simultaneously with the 25th Annual Meeting of the Japanese Society for Vaccinology (December 3–5, 2021) in Karuizawa.

We have prepared an exciting program for the symposium. We convey our deep appreciation to all participants for their understanding and kind cooperation. Please visit the homepage of the symposium to review the program.

This symposium consists of oral sessions (including three sponsored sessions) and poster session (on Day 1 at 14:00–16:00). A total of 30 papers will be presented in the oral sessions and 25 papers in the poster sessions. In the oral sessions, two Asian Pneumococcal Symposium plenary lectures are included. One is titled “Nasal delivery of a universal protein antigen identified by CRISPRi-seq induces broad protection from pneumococcal superinfection” and will be presented by Dr. Jan-Willem Veening (University of Lausanne, Switzerland) on Day 1 at 16:00. The other lecture is titled “Pneumococcal–host interactions affecting carriage and transmission” and will be presented by Dr. Jeff N. Weiser (New York University, USA) on Day 2 at 09:00. In the poster session, the best presenters will receive Poster Awards from the Program Committee.

We have also organized a joint session titled “Future outlook of presentation of respiratory infectious diseases: new modalities and scheme” on Day 2 at 16:30–18:00. This joint session includes two paper presentations. One is titled “Future perspectives of research and development in infectious disease prevention and future expectations of clinical applications” and will be presented by Dr. Norio Ohmagari (National Center for Global Health and Medicine, Japan). The other is titled “Past, now and future of monoclonal antibodies: from treatment to prevention in infectious disease” and will be presented by Dr. Susanna Esposito (Department of Pediatrics, Faculty of Medicine and Surgery, University of Parma, Italy).

In Japan, after the vaccination coverage against coronavirus disease 2019 reached over 70% among the target population, the incidence of coronavirus disease 2019 declined in late October 2021. However, it remains difficult for speakers from overseas to travel internationally at least until December 2021. Therefore, we have decided to organize the symposium online and via live streaming. So even if symposium participants are not able to visit the venue at Karuizawa, they will be able to live stream a Zoom meeting after completion of registration for the symposium.

We are delighted to welcome you to Karuizawa and look forward to seeing you soon. 

Best wishes,

Kazunori Oishi and Yuki Kinjo
The President of Symposium and Chairman of Scientific Organizing Committee.

President Office, Toyama Institute of Health
17-1, Nakataikoyama, Imizu City, Toyama
TEL: +81-766-56-5506
FAX: +81-766-56-7326